/Companies

Pionarus Bio, Inc.

1 known investors

Find your way into Pionarus Bio, Inc.

Pionarus develops synthetically produced, precision-designed cannabinoid compounds targeting women's health conditions such as menopause and metabolic disease. The company focuses on pharmaceutical-grade cannabinoid therapies optimized for target selectivity, oral bioavailability, and regulatory clarity.

Investors · 1

Frequently asked questions

What does Pionarus Bio, Inc. do?
Pionarus develops synthetically produced, precision-designed cannabinoid compounds targeting women's health conditions such as menopause and metabolic disease. The company focuses on pharmaceutical-grade cannabinoid therapies optimized for target selectivity, oral bioavailability, and regulatory clarity.
Who are Pionarus Bio, Inc.'s investors?
Pionarus Bio, Inc.'s investors include Colorado BioScience Association.